AGT Biosciences changes name to Chemgenex

By Melissa Trudinger
Tuesday, 29 June, 2004

AGT Biosciences has completed the last step in its merger with ChemGenex Therapeutics with the official name change of the company going through. Approval by AGT shareholders was obtained last week at an EGM.

From today, the company is to be known as ChemGenex Pharmaceuticals and will carry the ASX stock symbol 'CXS'.

Heart muscle regeneration genes mapped

Researchers have uncovered insights into how stem cells develop and mature into heart muscle...

The cause of 2022's mpox outbreak revealed

Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...

New gene therapy treats liver disorder in growing children

Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...

Content from other channels on our network

$2.5m to double circuit breaker production in Adelaide

Long-term water security project proposed for Hunter region

Engineering sustainability from the ground up at Selfs Point STP

Complex solar installation for Adelaide wine venue

Australia's data centre plans can become a blueprint for the world

Nurse-led infection control training program

Does frailty hold the key to early dementia diagnosis?

Tiny gold particles power golden staph colour test

The cost of not cleaning: how to reduce infections and save money

WA's women's, newborn and children's model remains a "major missed opportunity", doctors say

$2.5m to double circuit breaker production in Adelaide

ARENA announces new clean energy startup funding

Peak body wants engineering expertise at the heart of the AI future

$26 million to fund new Australian iron technology

Yokogawa launches cyber resilience centre for SE Asia and Oceania